Jump to main content
Jump to site search


Diagnosis of pancreatic cancer via 1H NMR metabolomics of human plasma

Author affiliations

Abstract

Metabolic changes induced by pancreatic cancer were investigated by 1H NMR spectroscopy of plasma samples of patients and healthy controls. The acquired data were submitted to multivariate statistical analysis providing clear discrimination between both groups. The most significant differences were found in levels of 3-hydroxybutyrate and lactate. The obtained results (100% sensitivity, 90% specificity) clearly show the potential of 1H NMR spectroscopy in pancreatic cancer diagnosis. Therefore, the NMR-based metabolomics may contribute to the early diagnosis, prevention and/or therapy of diseases in the future. On the other hand, the number of samples in the presented pilot study is limited and has to be significantly increased in the future in order to obtain solid statistical models and to confirm the current findings.

Graphical abstract: Diagnosis of pancreatic cancer via 1H NMR metabolomics of human plasma

Back to tab navigation

Publication details

The article was received on 15 Jul 2018, accepted on 20 Sep 2018 and first published on 21 Sep 2018


Article type: Paper
DOI: 10.1039/C8AN01310A
Citation: Analyst, 2018, Advance Article
  •   Request permissions

    Diagnosis of pancreatic cancer via 1H NMR metabolomics of human plasma

    L. Michálková, Š. Horník, J. Sýkora, L. Habartová and V. Setnička, Analyst, 2018, Advance Article , DOI: 10.1039/C8AN01310A

Search articles by author

Spotlight

Advertisements